STERIS plc (STE) Stock Analysis & Investment Frameworks
STERIS plc (STE) stock analysis on Invetso. Review STERIS plc’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
STERIS plc Company Overview
- Exchange: New York Stock Exchange
- Sector: Healthcare
- Industry: Medical - Specialties
- Country: US
STERIS plc Key Financial Metrics
- Market Cap: $22.64B
- Revenue: $5.94B
- P/E Ratio: 28.85
- ROE: 11.27%
- ROIC: 8.71%
- Dividend Yield: 1.11%
About STERIS plc
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. The company operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. It offers a range of products including cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, lights, and connectivity solutions. It also provides services such as equipment maintenance, instrument repair, and contract sterilization for medical device and pharmaceutical manufacturers.
STERIS plc Investment Frameworks
Invetso analyzes STERIS plc (STE) across the following frameworks:
- STERIS plc 10Y Growth Potential
- STERIS plc Scenario Analysis
- STERIS plc Risks & Opportunities
- STERIS plc Economic Moat
- STERIS plc Business Model
- STERIS plc Management
- STERIS plc SWOT Analysis
- STERIS plc Porter's 5 Forces
- STERIS plc PESTLE Analysis
- STERIS plc ESG Analysis